Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study

Daniel Pilsgaard Henriksen, Thomas Øhlenschlæger, Ann‐Cathrine Dalgaard Dunvald

Open source

DOI
10.1111/bcpt.70285
Published
2026-08-11
Container
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.70285,
  title = {Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study},
  author = {Daniel Pilsgaard Henriksen and Thomas Øhlenschlæger and Ann‐Cathrine Dalgaard Dunvald},
  year = {2026},
  journal = {Basic \& Clinical Pharmacology \& Toxicology},
  doi = {10.1111/bcpt.70285},
  url = {https://doi.org/10.1111/bcpt.70285}
}

RIS

TY  - JOUR
TI  - Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study
AU  - Daniel Pilsgaard Henriksen
AU  - Thomas Øhlenschlæger
AU  - Ann‐Cathrine Dalgaard Dunvald
PY  - 2026
JO  - Basic & Clinical Pharmacology & Toxicology
DO  - 10.1111/bcpt.70285
UR  - https://doi.org/10.1111/bcpt.70285
ER  - 

APA

Henriksen, D. P., Øhlenschlæger, T., & Dunvald, A. D. (2026). Use of STOPPFrail Medications Following Receipt of the Danish Terminal Grant: A Nationwide Descriptive Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70285

Source records